Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Collaboration to promote positive mental wellbeing
Dr Mike Topper, former AVMA President, with Prof Stuart Reid, Chair of the Mind Matters Initiative.

RCVS and AVMA team up to address veterinary mental health issues 

The RCVS has teamed up with the American Veterinary Medical Association (AVMA) to promote positive mental health and wellbeing across the veterinary profession.

The partnership will see the organisations collaborate on projects to advocate positive behaviour and support around mental health. They will also work on developing an evidence base and share best practice around interventions.

In a joint statement, the organisations said: “We believe that for veterinary professionals to realise their full potential and the global veterinary profession to remain sustainable, maintaining high levels of mental health and wellbeing for all members of the veterinary team is a priority.

“Improving veterinary mental health and wellbeing has a positive impact on individuals, the profession at large and, ultimately, animal health and welfare, and public health.”

The collaboration builds on the RCVS Mind Matters Initiative and AVMA’s Wellbeing and Peer Assistance initiative.

Professor Stuart Reid, chair of the RCVS Mind Matters Initiative said: “Regardless of where we live and work, as members of the veterinary profession we have many issues in common.

“The RCVS and AVMA have been discussing how we might best share ideas, resources and best practice for some time and I was delighted to meet with the senior officers of the AVMA at their recent convention in Denver.
 
“I firmly believe that in collaborating with the AVMA we will be able to address more effectively the pressing issues around mental health, and reinforce the many positives of working in such a wonderful profession.”
 
AVMA president Dr John de Jong said: “As two highly respected veterinary organisations in the increasingly global veterinary community, it is both logical and important that the AVMA and RCVS stand together speaking to the topic of mental health and wellbeing that affects people in our profession as much or more than among the general public.” 

The full joint statement between the AVMA and the RCVS can be found on the RCVS website.

Image (C) RCVS.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.